Susquehanna Fundamental Investments, LLC Xeris Biopharma Holdings, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $6.94 Billion
- Q1 2025
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 17,087 shares of XERS stock, worth $84,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,087
Previous 19,712
13.32%
Holding current value
$84,068
Previous $66,000
40.91%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
203Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$50.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$39.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$21.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$16.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $669M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...